Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor

Qiuhua Zhang1, Carl Soderland, Jena J Steinle

  • 1Department of Ophthalmology, University of Tennessee Health Science Center, 930 Madison Ave, Suite 768A, Memphis, TN 38163, USA.

Insights

The insulin-like growth factor binding protein-3 receptor (IGFBP-3 receptor) is essential for IGFBP-3 to prevent retinal endothelial cell death, particularly in high glucose conditions. This study confirms the receptor

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic retinopathy is a leading cause of blindness, characterized by retinal endothelial cell (REC) apoptosis.
  • Insulin-like growth factor binding protein-3 (IGFBP-3) has shown potential in protecting against apoptosis, but its specific receptor involvement in retinal cells was unclear.

Purpose of the Study:

  • To investigate the role of the IGFBP-3 receptor in mediating the anti-apoptotic effects of IGFBP-3 in retinal endothelial cells.
  • To determine if the IGFBP-3 receptor is necessary for IGFBP-3 to inhibit apoptosis in a hyperglycemic environment.

Main Methods:

  • Retinal endothelial cells were cultured in normal or high glucose conditions.
  • Cells were transfected with IGFBP-3 plasmid DNA and/or IGFBP-3 receptor siRNA.
  • Protein expression, receptor binding, and apoptosis markers (Bcl-xL, Bax, Cytochrome C, Akt) were analyzed using Western blotting and ELISAs.

Main Results:

  • The IGFBP-3 receptor was confirmed to be present on retinal endothelial cells.
  • Overexpression of IGFBP-3 increased IGFBP-3 receptor levels.
  • Silencing the IGFBP-3 receptor significantly increased cell death, indicating its protective role.

Conclusions:

  • The IGFBP-3 receptor is crucial for IGFBP-3 to inhibit retinal endothelial cell apoptosis, especially under hyperglycemic conditions.
  • This study provides the first evidence of IGFBP-3 receptor involvement in preventing REC cell death, opening avenues for therapeutic strategies in diabetic retinopathy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...